Showing results (851-860 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|March 5, 2016
Sample size determination for fold-increase endpoints defined by paired interval-censored dataYing Xu, K F Lam, Yin Bun CheungJournal of Biopharmaceutical Statistics|October 22, 2013
Dose-time-response modeling using negative binomial distributionMunmun Roy, Kanak Choudhury, M M Islam, et al.Journal of Biopharmaceutical Statistics|October 22, 2013
Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trialsBrian L Wiens, Alex Dmitrienko, Olga MarchenkoJournal of Biopharmaceutical Statistics|June 14, 2016
Power and sample size calculation for the additive hazard modelPei-Fang SuJournal of Biopharmaceutical Statistics|June 14, 2016
A novel evaluation of optimality for randomized controlled trialsJo Wick, Scott M Berry, Hung-Wen Yeh, et al.Journal of Biopharmaceutical Statistics|December 19, 2017
Partially linear mixed-effects joint models for skewed and missing longitudinal competing risks outcomesTao Lu, Minggen Lu, Min Wang, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
The stratified win ratioGaohong Dong, Junshan Qiu, Duolao Wang, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
Combination of the weighted kappa coefficients of two binary diagnostic testsJ A Roldán-Nofuentes, R M AmroJournal of Biopharmaceutical Statistics|November 28, 2017
Advancing cancer drug development through precision medicine and innovative designsWeidong Zhang, Jing Wang, Sandeep MenonJournal of Biopharmaceutical Statistics|September 8, 2017
MODELING ANTI-KLH ELISA DATA USING TWO-STAGE AND MIXED EFFECTS MODELS IN SUPPORT OF IMMUNOTOXICOLOGICAL STUDIESZiv Shkedy, Roel Straetemans, Geert Molenberghs, et al.Pageof 216